TrialDiabetologia2015

Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study.

Kwok-Leung Ong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.